Skip to content

    PACIFIC BIOSCIENCES OF CALIFORNIA (PACB) stock price & financials

    View PACB earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+5.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $39.97M
    $39.22M
    $37.15M
    $39.77M
    $38.44M
    -3.8%
    $44.65M
    +13.8%
    $37.18M
    +0.1%
    $39.01M
    -1.9%
    Strengthening
    Operating Profit
    -$64.08M
    -$153.03M
    -$428.93M
    -$44.85M
    -$38.88M
    +39.3%
    -$41.20M
    +73.1%
    -$8.36M
    +98.1%
    -$44.61M
    +0.5%
    Strengthening
    Net Profit
    -$60.73M
    $2.37M
    -$426.07M
    -$41.93M
    -$38.00M
    +37.4%
    -$40.37M
    -1802.7%
    -$8.28M
    +98.1%
    -$44.74M
    -6.7%
    Weakening
    EPS
    $-0.22
    $-1.44
    $-0.14
    $-0.13
    +40.9%
    $-0.03
    +97.9%
    $-0.14
    +0.0%
    Strengthening
    Other Income
    Interest
    $3.54M
    $2.76M
    $1.74M
    $1.74M
    $1.74M
    -50.8%
    $1.74M
    -36.9%
    $1.74M
    +0.2%
    $2.11M
    +21.4%
    Weakening
    Depreciation
    Profit before Tax
    -$60.73M
    $2.69M
    -$426.38M
    -$41.90M
    -$37.62M
    +38.1%
    -$40.17M
    -1594.9%
    -$8.09M
    +98.1%
    -$44.68M
    -6.7%
    Weakening
    MarginsOPM
    -160.3%
    -390.1%
    -1154.5%
    -112.8%
    -101.1%
    +36.9%
    -92.3%
    +76.3%
    -22.5%
    +98.1%
    -114.4%
    -1.4%
    Strengthening
    Tax
    0.0%
    11.8%
    0.1%
    -0.1%
    -1.0%
    -0.5%
    -104.3%
    -2.3%
    -3342.9%
    -0.1%
    -62.5%
    Weakening
    ReturnsROIC
    2.2%
    -0.1%
    15.5%
    1.5%
    1.4%
    -37.4%
    1.5%
    0.3%
    -98.1%
    1.6%
    +6.7%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$18.84M$29.63M$81.61M$460.73M$325.09M$179.91M$55.37M$63.71M$61.00M
    Short-Term Investments
    Total Current Assets$131.66M$81.05M$355.59M$1.10B$852.07M$742.05M$495.68M$375.05M$338.64M
    Net PP&E$34.07M$62.90M$54.85M$79.12M$81.34M$69.03M$46.60M$65.84M$67.30M
    Goodwill$409.97M$409.97M$462.26M$317.76M$317.76M$317.76M
    Intangibles$410.98M$410.25M$456.98M$389.57M$15.12M$13.08M
    Total Assets$170.28M$147.99M$413.98M$2.01B$1.77B$1.75B$1.26B$784.08M$751.85M
    LiabilitiesTotal Current Liabilities$26.88M$49.15M$38.50M$71.71M$263.33M$95.03M$66.30M$72.83M$68.81M
    Short-Term Debt$1.61M$1.84M$490.0K$0
    Long-Term Debt$14.66M$15.87M$896.07M$896.68M
    Long-Term Leases$41.96M$37.67M$49.97M$41.07M$31.61M$14.91M$56.59M$60.42M
    Total Liabilities$56.21M$93.07M$78.49M$1.22B$1.20B$1.04B$753.85M$778.73M$785.06M
    EquityCommon Stock & APIC$150.0K$153.0K$192.0K$221.0K$227.0K$268.0K$294.0K$302.0K$311.0K
    Retained Earnings-$982.11M-$1.07B-$1.04B-$1.22B-$1.53B-$1.84B-$2.15B-$2.70B-$2.75B
    Total Equity$114.06M$54.92M$335.49M$790.99M$562.90M$701.30M$506.59M$5.35M-$33.21M
    HighlightsNet Cash / (Debt)-$436.95M-$573.44M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$66.43M-$78.31M$19.50M-$111.18M-$263.21M-$259.17M-$206.06M-$111.21M-$118.05M
    Cash from Investing-$38.41M$62.05M-$219.32M-$678.53M$116.08M$4.60M$124.00M$115.45M$120.86M
    Cash from Financing$107.18M$26.55M$251.84M$1.17B$9.62M$108.89M-$42.99M$3.43M$3.16M
    SummaryCapital Expenditure-$1.85M-$2.84M-$1.04M-$5.93M-$16.75M-$8.84M-$6.19M-$2.71M-$5.37M
    Free Cash Flow-$68.28M-$81.15M$18.46M-$117.11M-$279.96M-$268.02M-$212.25M-$113.92M-$123.42M
    FCF Margin-86.8%-89.3%23.4%-89.7%-218.2%-133.7%-137.8%-71.2%-77.5%

    Ratios